Plant ID: NPO19994
Plant Latin Name: Scutellaria viscidula
Taxonomy Genus: Scutellaria
Taxonomy Family: Lamiaceae
NCBI TaxonomyDB:
512023
Plant-of-the-World-Online:
n.a.
China
ADA; | |
BCL2; | |
FLT3; MAPK1; | |
TERT; | |
SLCO1B3; SLCO1B1; | |
CREB1; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Hydrolase | ADA | Adenosine deaminase | P00813 | CHEMBL1910 |
Miscellaneous ion channel | BCL2 | Apoptosis regulator Bcl-2 | P10415 | CHEMBL4860 |
Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Unclassified | CREB1 | Cyclic AMP-responsive element-binding protein 1 | P16220 | CHEMBL5587 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0035094; response to nicotine | 7.390E-07 | 6.472E-03 | BCL2, CREB1, MAPK1 |
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 8.917E-07 | 6.472E-03 | ADA, BCL2, CREB1, MAPK1, TERT |
BP | GO:0032502; developmental process | GO:0007568; aging | 2.396E-06 | 1.004E-02 | ADA, BCL2, CREB1, TERT |
BP | GO:0032502; developmental process | GO:0048732; gland development | 2.883E-06 | 1.004E-02 | ADA, BCL2, CREB1, MAPK1 |
BP | GO:0065007; biological regulation | GO:0031647; regulation of protein stability | 3.228E-06 | 1.004E-02 | BCL2, CREB1, MAPK1, TERT |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 3.775E-06 | 1.027E-02 | ADA, BCL2, CREB1, TERT |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 2.941E-05 | 2.911E-02 | SLCO1B1, SLCO1B3 |
MF | GO:0005488; binding | GO:0001223; transcription coactivator binding | 3.651E-05 | 3.456E-02 | CREB1, TERT |
MF | GO:0005215; transporter activity | GO:0015347; sodium-independent organic anion transmembrane transporter activity | 5.298E-05 | 4.615E-02 | SLCO1B1, SLCO1B3 |
CC | GO:0044464; cell part | GO:0032839; dendrite cytoplasm | 5.757E-05 | 4.677E-02 | ADA, MAPK1 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 4.200E-04 | 1.055E-01 | ADA, MAPK1 |
MF | GO:0005488; binding | GO:0042802; identical protein binding | 4.012E-04 | 1.055E-01 | BCL2, CREB1, FLT3, MAPK1, TERT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 7.018E-06 | 4.281E-04 | CREB1, BCL2, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 1.364E-05 | 5.547E-04 | CREB1, BCL2, MAPK1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 3.547E-06 | 4.281E-04 | SLCO1B1, SLCO1B3, CYP3A4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 3.100E-05 | 7.877E-04 | CREB1, BCL2, MAPK1 |
09150 Organismal Systems | 09153 Circulatory system | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.228E-05 | 7.877E-04 | CREB1, BCL2, MAPK1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05152 | Tuberculosis | 5.598E-05 | 1.138E-03 | CREB1, BCL2, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 2.836E-04 | 4.782E-03 | FLT3, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04151 | PI3K-Akt signaling pathway | 3.824E-04 | 4.782E-03 | CREB1, BCL2, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 3.357E-04 | 4.782E-03 | BCL2, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 5.965E-04 | 6.616E-03 | FLT3, BCL2, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 3.920E-04 | 4.782E-03 | FLT3, MAPK1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 8.883E-04 | 7.042E-03 | BCL2, MAPK1 |
09150 Organismal Systems | 09159 Environmental adaptation | hsa04713 | Circadian entrainment | 7.865E-04 | 7.042E-03 | CREB1, MAPK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 8.537E-04 | 7.042E-03 | CREB1, MAPK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04916 | Melanogenesis | 8.709E-04 | 7.042E-03 | CREB1, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04668 | TNF signaling pathway | 1.052E-03 | 7.552E-03 | CREB1, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 9.235E-04 | 7.042E-03 | BCL2, MAPK1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 1.209E-03 | 7.627E-03 | BCL2, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 1.250E-03 | 7.627E-03 | BCL2, MAPK1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.696E-03 | 9.405E-03 | BCL2, MAPK1 |
09150 Organismal Systems | 09158 Development | hsa04380 | Osteoclast differentiation | 1.510E-03 | 8.771E-03 | CREB1, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 1.250E-03 | 7.627E-03 | BCL2, MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Immunodeficiency | D84.9 | ADA; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Chronic pain | R52.1-R52.2, G89 | ADA; |
C00-D49: Neoplasms | Hairy cell leukemia | C91.4 | ADA; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | ADA; |